IL101683A0 - Method and assay system for neurotrophin activity - Google Patents
Method and assay system for neurotrophin activityInfo
- Publication number
- IL101683A0 IL101683A0 IL101683A IL10168392A IL101683A0 IL 101683 A0 IL101683 A0 IL 101683A0 IL 101683 A IL101683 A IL 101683A IL 10168392 A IL10168392 A IL 10168392A IL 101683 A0 IL101683 A0 IL 101683A0
- Authority
- IL
- Israel
- Prior art keywords
- assay system
- neurotrophin activity
- neurotrophin
- activity
- assay
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72878491A | 1991-07-03 | 1991-07-03 | |
US76267591A | 1991-09-20 | 1991-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL101683A0 true IL101683A0 (en) | 1992-12-30 |
Family
ID=27111743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL101683A IL101683A0 (en) | 1991-07-03 | 1992-04-23 | Method and assay system for neurotrophin activity |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0593663A4 (en) |
JP (1) | JPH06509333A (en) |
AU (1) | AU2322392A (en) |
CA (1) | CA2112799A1 (en) |
IE (1) | IE921315A1 (en) |
IL (1) | IL101683A0 (en) |
NZ (1) | NZ242467A (en) |
PT (1) | PT100424A (en) |
WO (1) | WO1993000909A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993025683A1 (en) * | 1992-06-12 | 1993-12-23 | Massachusetts Institute Of Technology | A gene which prevents programmed cell death |
US6902732B2 (en) | 1992-06-12 | 2005-06-07 | Massachusetts Institute Of Technology | Identification and characterization of a gene which protects cells from programmed cell death and uses therefor |
US5461146A (en) * | 1992-07-24 | 1995-10-24 | Cephalon, Inc. | Selected protein kinase inhibitors for the treatment of neurological disorders |
WO1994027982A1 (en) * | 1993-05-28 | 1994-12-08 | Cephalon, Inc. | Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
US5468872A (en) * | 1993-09-16 | 1995-11-21 | Cephalon, Inc. | K-252a functional derivatives potentiate neurotrophin-3 for the treatment of neurological disorders |
US5602309A (en) * | 1993-10-04 | 1997-02-11 | University Of Kentucky Research Foundation | Transgenic mice which overexpress nerve growth factor |
WO1995022331A1 (en) * | 1994-02-18 | 1995-08-24 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
JPH11509193A (en) * | 1995-06-27 | 1999-08-17 | ヘンリー エム.ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン | A method for dynamically delaying cell cycle dynamics to enhance cell injury |
US6274576B1 (en) | 1995-06-27 | 2001-08-14 | The Henry Jackson Foundation For The Advancement Of Military Medicine | Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
US5859311A (en) * | 1995-11-27 | 1999-01-12 | University Of Kentucky Research Foundation | Transgenic mice which overexpress neurotrophin-3 (NT-3) and methods of use |
US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
CA2524883C (en) | 2003-05-16 | 2014-07-22 | Universite Laval | Potassium-chloride cotransporter kcc2 modulation for treatment of pain |
JP2007537167A (en) | 2004-05-14 | 2007-12-20 | ユニヴェルシテ ラヴァル | Regulation of phospholipase C gamma and thereby regulation of pain and nociception |
EP2294183B1 (en) | 2008-06-18 | 2015-12-16 | The Texas A&M University System | Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage |
WO2013138374A2 (en) * | 2012-03-15 | 2013-09-19 | Curna, Inc. | Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
US20150133529A1 (en) * | 2012-05-16 | 2015-05-14 | Rana Therapeutics, Inc. | Compositions and methods for modulating bdnf expression |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
-
1992
- 1992-04-23 CA CA002112799A patent/CA2112799A1/en not_active Abandoned
- 1992-04-23 EP EP92915861A patent/EP0593663A4/en not_active Withdrawn
- 1992-04-23 PT PT100424A patent/PT100424A/en not_active Application Discontinuation
- 1992-04-23 AU AU23223/92A patent/AU2322392A/en not_active Abandoned
- 1992-04-23 IE IE131592A patent/IE921315A1/en unknown
- 1992-04-23 WO PCT/US1992/003392 patent/WO1993000909A1/en not_active Application Discontinuation
- 1992-04-23 NZ NZ242467A patent/NZ242467A/en unknown
- 1992-04-23 IL IL101683A patent/IL101683A0/en unknown
- 1992-04-23 JP JP5502196A patent/JPH06509333A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2322392A (en) | 1993-02-11 |
EP0593663A1 (en) | 1994-04-27 |
NZ242467A (en) | 1995-06-27 |
WO1993000909A1 (en) | 1993-01-21 |
IE921315A1 (en) | 1993-01-13 |
CA2112799A1 (en) | 1993-01-21 |
PT100424A (en) | 1993-10-29 |
EP0593663A4 (en) | 1996-10-30 |
JPH06509333A (en) | 1994-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2227981B (en) | Active suspension system and method for controlling same | |
EP0586259A3 (en) | Sign-language learning system and method | |
AU2864989A (en) | Location system and method | |
EP0426393A3 (en) | Instructing method and execution system | |
EP0766651A4 (en) | Controlled denitrification process and system | |
AU2029592A (en) | Fastening system and method | |
AU1875692A (en) | Exhaust treatment system and method | |
EP0480726A3 (en) | Pulse analysis system and method | |
IL101683A0 (en) | Method and assay system for neurotrophin activity | |
LTIP1892A (en) | Corrosian analysis system and method | |
EP0533196A3 (en) | Version-up method and system | |
EP0549248A3 (en) | An arbitration system and method | |
GB2236270B (en) | System and apparatus for assembling workpieces | |
GB2206468B (en) | Contention control system and method | |
GB2266167B (en) | Communicating system and method for communicating data | |
GB2265718B (en) | Assay apparatus and assay method | |
EP0435086A3 (en) | Trailer anti-swing system and method | |
ZA922947B (en) | Assay systems for neurotrophin activity | |
GB8906647D0 (en) | An interaction support system and method | |
GB2273380B (en) | Data processing system and data processing method using same | |
GB2273787B (en) | Developing method and system | |
GB8906951D0 (en) | Method and system for construction | |
GB9224401D0 (en) | Turfing system and method | |
GB8918336D0 (en) | Means and method for performing an activity | |
EP0802888A4 (en) | Aeration system and method |